Company / Operating Income per Share
Pacira BioSciences, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.42
FY2025
5-year range
-$1.59 / $1.91
FY2021-FY2025
Trend
+126.2%
vs FY2024
Sector context
#48 of 201
Health Care
What the data says
Pacira BioSciences, Inc.'s operating income per share of $0.42 is higher than 76% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-1.59 in FY2024 to $1.91 in FY2023.
Based on SEC 10-K filings.
0.42 in FY2025 with a 5-year CAGR of +1.8%. Top quartile in the Health Care sector.
Declined from $1.91 to $0.42 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -32.4%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -
Sector benchmark
+112.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 126.2% year-over-year.
- Ranks #48 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.42 | +126.2% |
| FY2024 | -$1.59 | -183.1% |
| FY2023 | $1.91 | +42.3% |
| FY2022 | $1.34 | +458.7% |
| FY2021 | $0.24 | -36.8% |
| FY2020 | $0.38 | +162.8% |
| FY2019 | -$0.60 | +23.2% |
| FY2018 | -$0.79 | -412.1% |
| FY2017 | $0.25 | +129.0% |
| FY2016 | -$0.87 | -432.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026